Work

Preclinical identification of biomarkers of response to mTOR inhibitors and subsequent application in a phase II trial of sirolimus in pancreatic cancer patients refractory to gemcitabine

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.4612

Authors: I. Garrido-Laguna, M. Rudek, A. Tan, M. Uson, C. Iacobuzio-Donahue, M. Angenendt, A. Jimeno, D. Laheru, M. Barret, M. Hidalgo

Institutions: Translational Genomics Research Institute, Johns Hopkins University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2966825946

Cites:

Cited by: 5

Related to: 10